Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials
Maëlle Duffey, Benjamin Blasco, Jeremy N. Burrows, et al.
Trends in Parasitology (2021) Vol. 37, Iss. 8, pp. 709-721
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Antimalarial drug discovery: progress and approaches
Jair L. Siqueira-Neto, Kathryn J. Wicht, Kelly Chibale, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 807-826
Open Access | Times Cited: 93
Prioritization of Molecular Targets for Antimalarial Drug Discovery
Barbara Forte, Sabine Ottilie, Andrew Plater, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 10, pp. 2764-2776
Open Access | Times Cited: 70
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria
E. Schmitt, Gilles Ndayisaba, Adoke Yeka, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 10, pp. 1831-1839
Open Access | Times Cited: 62
Transmission-blocking drugs for malaria elimination
Lyn‐Marié Birkholtz, Pietro Alano, Didier Leroy
Trends in Parasitology (2022) Vol. 38, Iss. 5, pp. 390-403
Open Access | Times Cited: 58
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum
Krittikorn Kümpornsin, Theerarat Kochakarn, Tomas Yeo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Swaroop Kumar Pandey, Uttpal Anand, Waseem Ahmad Siddiqui, et al.
Advances in Medicine (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 25
Combating antimicrobial resistance in malaria, HIV and tuberculosis
Maëlle Duffey, Robert W. Shafer, Juliano Timm, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 461-479
Closed Access | Times Cited: 9
Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target
Eva S. Istvan, Francisco Guerra, Matthew Abraham, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 686
Open Access | Times Cited: 18
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
Laura E. de Vries, Patrick A.M. Jansen, Catalina Barceló, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages
Lauren B. Arendse, James M. Murithi, Tarrick Qahash, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 25
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway
Rebecca Edgar, Ghizal Siddiqui, Katheryn Hjerrild, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 24
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362
Martin A. Lowe, Á. de Pablo Cárdenas, Jean‐Pierre Valentin, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 14121-14143
Open Access | Times Cited: 23
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
Ioanna Deni, Barbara H. Stokes, Kurt E. Ward, et al.
Cell chemical biology (2023) Vol. 30, Iss. 5, pp. 470-485.e6
Open Access | Times Cited: 16
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
Trent D. Ashton, Madeline G. Dans, Paola Favuzza, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3540-3565
Open Access | Times Cited: 13
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3
Petar P. S. Calic, Trent D. Ashton, Mahta Mansouri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116677-116677
Open Access | Times Cited: 5
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome
Stanley C. Xie, Riley D. Metcalfe, Hirotake Mizutani, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 39
Open Access | Times Cited: 28
Transition Metal Complexes as Antimalarial Agents: A Review
Apurba Mandal, Rajesh Kushwaha, Arif Ali Mandal, et al.
ChemMedChem (2023) Vol. 18, Iss. 19
Closed Access | Times Cited: 12
Asian Ancistrocladus Lianas as Creative Producers of Naphthylisoquinoline Alkaloids
Doris Feineis, Gerhard Bringmann
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2023), pp. 1-335
Closed Access | Times Cited: 11
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase
Stanley C. Xie, Wang Yi-nuo, Craig J. Morton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Defining the next generation of severe malaria treatment: a target product profile
Jane Achan, Aïssata Barry, Didier Leroy, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy
Godwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11401-11420
Open Access | Times Cited: 4
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
Mark A. Tye, N. Connor Payne, C. Johansson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Antimalarial Drug Strategies to Target Plasmodium Gametocytes
Bruce A. Munro, Brendan J. McMorran
Parasitologia (2022) Vol. 2, Iss. 2, pp. 101-124
Open Access | Times Cited: 18
Current and emerging target identification methods for novel antimalarials
Matthew Challis, Shane M. Devine, Darren J. Creek
International Journal for Parasitology Drugs and Drug Resistance (2022) Vol. 20, pp. 135-144
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top